In this ongoing trial 3-month therapy with human lymphoblastoid interferon in patients with anti-HBe and HBV-DNA positive chronic hepatiits resulted in complete disappearance of HBV-DNA from serum in 3 of 7 (43%) treated patients compared to 1 of 6 (16%) contro subjects.

AntiHBe and HBV-DNA positive chronic hepatitis B: clinical aspects and response to interferon therapy.

FATTOVICH, Giovanna;
1987

Abstract

In this ongoing trial 3-month therapy with human lymphoblastoid interferon in patients with anti-HBe and HBV-DNA positive chronic hepatiits resulted in complete disappearance of HBV-DNA from serum in 3 of 7 (43%) treated patients compared to 1 of 6 (16%) contro subjects.
1851130721
chronic hepatitis B; anti-HBe positive; interferon therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/435012
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact